These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1080678)

  • 41. Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.
    Jenkins CS; Meyer D; Dreyfus MD; Larrieu MJ
    Br J Haematol; 1974 Dec; 28(4):561-78. PubMed ID: 4141901
    [No Abstract]   [Full Text] [Related]  

  • 42. Heterogeneity in von Willebrand's disease.
    Ruggeri ZM; Zimmerman TS
    Prog Clin Biol Res; 1981; 72():139-48. PubMed ID: 6801683
    [No Abstract]   [Full Text] [Related]  

  • 43. Differentiation of patients with subtype IIb-like von Willebrand's disease by means of perfusion experiments with reconstituted blood.
    Sakariassen KS; Nieuwenhuis HK; Sixma JJ
    Br J Haematol; 1985 Mar; 59(3):459-70. PubMed ID: 3918560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proceedings: Abnormal factor VIII in von Willebrand's disease.
    Thompson C; Forbes CD; Prentice CR
    Br J Haematol; 1974 Sep; 28(1):144. PubMed ID: 4547281
    [No Abstract]   [Full Text] [Related]  

  • 45. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease.
    Egberg N; Blombäck M
    Thromb Res; 1976 Nov; 9(5):527-31. PubMed ID: 1087055
    [No Abstract]   [Full Text] [Related]  

  • 47. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 48. The platelet in von Willebrand's disease: interactions with ristocetin and factor VIII.
    Walsh RT
    Semin Thromb Hemost; 1975 Oct; 2(2):105-115. PubMed ID: 798270
    [No Abstract]   [Full Text] [Related]  

  • 49. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
    Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
    Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
    [No Abstract]   [Full Text] [Related]  

  • 50. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Letter: Relation of von Willebrand factor to bleeding time.
    Weiss HJ
    N Engl J Med; 1974 Aug; 291(8):420. PubMed ID: 4546558
    [No Abstract]   [Full Text] [Related]  

  • 52. Aortic valve replacement in von Willebrand's disease.
    Young PH; Bouhasin JD; Barner HB
    J Thorac Cardiovasc Surg; 1978 Aug; 76(2):218-22. PubMed ID: 308120
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
    Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
    Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities.
    Hougie C; Sargeant RB; Brown JE; Baugh RF
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194
    [No Abstract]   [Full Text] [Related]  

  • 56. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on the pathophysiology and treatment of von Willebrand's disease. III. Binding of plasma factor VIII to platelets in the presence of ristocetin.
    Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1981 Jul; 44(4):910-20. PubMed ID: 6800183
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.
    Girolami A; Fabris F; Marco L; Peruffo R
    Acta Haematol; 1976; 56(3):151-9. PubMed ID: 826070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. von Willebrand's disease: current concepts.
    Green D; Chediak JR
    Am J Med; 1977 Mar; 62(3):315-8. PubMed ID: 300223
    [No Abstract]   [Full Text] [Related]  

  • 60. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K; Kubonishi I; Taguchi H; Miyoshi I
    Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.